Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies

Overview of attention for article published in Neurology: Neuroimmunology and Neuroinflammation, October 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 14,033 followers.

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies https://t.co/hPcaQTlH3e https://t.co/qj7BvGO9FP

Data "support planned preconception use of [ocrelizumab] w/o necessary continuation into pregnancy or [natalizumab] continuation up to 28–32 wks...with early reinitiation after delivery as effective strategies to⬇️disease activity during &after pregna…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.